Trademarkia Logo

Canada

C$
SONATA THERAPEUTICS
SEARCHED

on 12 Jul 2024

Last Applicant/ Owned by

Sonata Therapeutics, Inc.

500 Arsenal Street, Suite 100, Watertown MA 02472

US

Serial Number

2250073 filed on 21st Nov 2022

Correspondent Address

SMART & BIGGAR LP

Scotia Plaza, 40 King Street West40th FloorToronto

ONTARIO

CA

M5H3Y2

SONATA THERAPEUTICS

Trademark usage description

pharmaceutical agents and products for cellular signal modulation, namely, compositions that modulate signaling pathways involved in disease processes Read More

Classification Information


Class [005]
Pharmaceutical agents and products for cellular signal modulation, namely, compositions that modulate signaling pathways involved in disease processes to treat immune and inflammatory diseases, neurological diseases, infectious disease, and for use in regenerative medicine; therapeutic products, namely therapeutic compositions for cellular signal modulation to modulate signaling pathways involved in disease processes, cell regeneration for treating immune and inflammatory diseases, neurological diseases, infectious disease, and for use in regenerative medicine; therapeutic products for cellular signal modulation, namely, compositions that modulate signaling pathways involved in disease processes, cell regeneration in the nature of chemical and biological small molecules; pharmaceutical compositions in the nature of chemical and biological small molecules for cellular signal modulation namely compositions that modulate signaling pathways involved in disease processes, cell regeneration for treatment of immune and inflammatory diseases, neurological diseases, infectious disease for use in regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation, namely compositions that modulate signaling pathways involved in disease processes, cell regeneration


Classification kind code

11

Class [042]
Scientific research, pharmaceutical research, and medical research in the fields of pharmaceutical research and development and biotechnology for others; product development for others in the field of biotechnology; development of pharmaceuticals and therapeutic agents for others; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; platform as a service (PaaS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals.


Classification kind code

11

Mark Details


Serial Number

2250073

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 12th Jul 2024
Search Recorded
Submitted for opposition 20
on 12th Jul 2024
Examiner's First Report
Submitted for opposition 223
on 12th Jul 2024
Total Provisional Refusal
Submitted for opposition 256
on 6th Feb 2024
Notification of Possible Opposition Sent
Submitted for opposition 135
on 18th May 2023
Amendment to Application
Submitted for opposition 257
on 6th Apr 2023
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 5th Apr 2023
Formalized
Submitted for opposition 1
on 5th Apr 2023
Created
Submitted for opposition 228
on 21st Nov 2022
International Registration
Submitted for opposition 30
on 21st Nov 2022
Filed